Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation

Imdad Ahmed, Elie Gertner, William B. Nelson, Chad M. House, Ranjan Dahiya, Christopher P. Anderson, David G. Benditt, Dennis W X Zhu

Research output: Contribution to journalArticlepeer-review

81 Scopus citations

Fingerprint Dive into the research topics of 'Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation'. Together they form a unique fingerprint.

Medicine & Life Sciences